|
Demographics and characteristics of participating children and adolescents |
|||||
| Children/adolescents |
Dutch |
Moroccan |
Turkish |
Surinamese |
Total |
|
|
|||||
| Total number of participating young children (7–12 years) |
5 |
10 |
6 |
5 |
26 |
| Gender |
|||||
| boys |
2 |
4 |
4 |
3 |
13 |
| girls |
3 |
6 |
2 |
2 |
13 |
| Medication |
|||||
| inhaled corticosteroids |
5 |
9 |
5 |
5 |
24 |
| Bronchodilators |
4 |
9 |
6 |
5 |
24 |
| Asthma control¶ |
|||||
| well controlled |
4 |
4 |
3 |
3 |
14 |
| not well controlled |
1 |
6 |
3 |
2 |
12 |
| Total number of participating adolescents (13–17 years) |
3 |
4 |
3 |
4 |
14 |
| Gender |
|||||
| boys |
3 |
4 |
3 |
4 |
14 |
| girls |
0 |
0 |
0 |
0 |
0 |
| Medication |
|||||
| inhalation corticosteroids |
2 |
4 |
3 |
4 |
13 |
| bronchodilators |
3 |
4 |
3 |
4 |
14 |
| Asthma control¶ |
|||||
| well controlled |
1 |
2 |
1 |
2 |
6 |
| not well controlled |
2 |
2 |
2 |
2 |
8 |
|
¶ information from results multicentre study | |||||
van Dellen et al. BMC Public Health 2008 8:380 doi:10.1186/1471-2458-8-380 |
|||||